Arcellx/$ACLX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Arcellx
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Ticker
$ACLX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
163
ISIN
US03940C1009
Website
Arcellx Metrics
BasicAdvanced
$3.6B
-
-$3.00
0.34
-
Price and volume
Market cap
$3.6B
Beta
0.34
52-week high
$107.37
52-week low
$47.86
Average daily volume
846K
Financial strength
Current ratio
4.928
Quick ratio
4.856
Long term debt to equity
10.993
Total debt to equity
12.759
Interest coverage (TTM)
-419.95%
Management effectiveness
Return on assets (TTM)
-16.69%
Return on equity (TTM)
-35.56%
Valuation
Price to revenue (TTM)
46.24
Price to book
8.66
Price to tangible book (TTM)
8.66
Price to free cash flow (TTM)
-28.996
Growth
Revenue change (TTM)
-41.66%
Earnings per share change (TTM)
193.88%
3-year earnings per share growth (CAGR)
-40.68%
Arcellx News
AllArticlesVideos
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Business Wire·1 week ago
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Seeking Alpha·3 weeks ago
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Seeking Alpha·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Arcellx stock?
Arcellx (ACLX) has a market cap of $3.6B as of May 23, 2025.
What is the P/E ratio for Arcellx stock?
The price to earnings (P/E) ratio for Arcellx (ACLX) stock is 0 as of May 23, 2025.
Does Arcellx stock pay dividends?
No, Arcellx (ACLX) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Arcellx dividend payment date?
Arcellx (ACLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Arcellx?
Arcellx (ACLX) has a beta rating of 0.34. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.